AM6545, >=98% (HPLC)

AM6545, >=98% (HPLC)

Biochem/physiol Actions

AM6545 is a peripheral CB1 cannabinoid receptor antagonist and appetite suppressant.

AM6545 helps in decreasing the development of albuminuria, inflammation and expression of markers of fibrosis. It also helps in the down-regulation of nephrin and podocin. It has the ability to repress the ingestion of food and food-reinforced behaviour.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

General description

AM6545 is a cannabinoid (CB1) receptor antagonist.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573242 AM6545, >=98% (HPLC) white to off-white 100 XBHQLFVDGLPBCK-UHFFFAOYSA-N 1S/C26H23Cl2N5O3S/c1-18-24(26(34)31-32-13-15-37(35,36)16-14-32)30-33(23-11-10-21(27)17-22(23)28)25(18)20-8-6-19(7-9-20)5-3-2-4-12-29/h6-11,17H,2,4,13-16H2,1H3, SIGMA-ALDRICH DMSO: >25 mg/mL powder ≥98% (HPLC)
£1,014.00 (exc VAT) per 25MG
-
+
3573243 AM6545, >=98% (HPLC) white to off-white 100 XBHQLFVDGLPBCK-UHFFFAOYSA-N 1S/C26H23Cl2N5O3S/c1-18-24(26(34)31-32-13-15-37(35,36)16-14-32)30-33(23-11-10-21(27)17-22(23)28)25(18)20-8-6-19(7-9-20)5-3-2-4-12-29/h6-11,17H,2,4,13-16H2,1H3, SIGMA-ALDRICH DMSO: >25 mg/mL powder ≥98% (HPLC)
£318.96 (exc VAT) per 5MG
-
+